Clinical Trial Update: Azacitidine + Venetoclax VS Azacitidineas Maintenance Therapy in AML [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing azacitidine plus venetoclax to azacitidine maintenance therapy in acute myeloid leukemia; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Venetoclax (venetoclax)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: AML | Phase 3 | Status: NOT_YET_RECRUITING